University of California San Francisco
Give to UCSF
In a perspective published by the New England Journal of Medicine, UCSF's Elizabeth Watkins shares a historical perspective of pharmaceutical advertising and proposes a new approach for educating consumers.
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.
UCSF ranks among the world’s leading research universities for the ninth year in a row, according to the 2015 Academic Ranking of World Universities.
Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry.
Medications commonly used to treat dementia could result in harmful weight loss, and clinicians need to account for this risk when prescribing these drugs to older adults, a new UCSF study says.
A team of UC San Francisco and Stanford University scientists has discovered that a protein thought to be crucial for the body to develop and function correctly can be reduced by half in mice with no apparent ill effects.
In the state of Tikray in northern Ethiopia, where poverty and unemployment are rampant, very few have the fortune to go to college. But Getahun Weldeselassie nevertheless banked on education as his best shot at a better life.
Withholding angiotensin receptor blockers for longer than two days after surgery is associated with a significantly increased risk of postoperative death, according to a study of more than 30,000 patients.
About a quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to UCSF researchers.
Researchers at UCSF have pulled aside the curtain on a protein informally known as the “wasabi receptor,” revealing at near-atomic resolution structures that could be targeted with anti-inflammatory pain drugs.
UCSF scientists have identified a biological escape hatch that explains the resistance to targeted drug treatment in some lung cancer patients.
A research team, led by a UCSF biologist, has isolated energy-burning “beige” fat from adult humans, which is known to be able to convert unhealthy white fat into healthy brown fat.
William DeGrado, PhD, a UC San Francisco researcher, has won a prestigious award from the Protein Society, an international organization dedicated to supporting protein research.
A new study of acute lymphoblastic leukemia has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of cases may be successfully treated with targeted drugs.
The National Academy of Sciences has bestowed UC San Francisco’s Jonathan Weissman, PhD, its the inaugural NAS Award for Scientific Discovery – presented in the field of chemistry, biochemistry, or biophysics.
